Skip to main content
Drug Name Tocilizumab
Drug Class
Immunosuppressant
Risk minimization type
Safety communication
Specialty (Theraputic area)
Rheumatology
Risk

Potential Risk of Acute Generalized Exanthematous Pustulosis (AGEP) Associated with the Use of Tocilizumab

safety communication